Confidentiality Document Intellectual Property Public Use 
IP Intelligence
JULY 19, 2024
Patent and Trademark Office (USPTO) recently issued guidance on the use of artificial intelligence (AI), particularly generative AI, in Intellectual Property (IP) practices involving documents filed at the USPTO. AI also cannot hold a USPTO account or independently access a practitioner’s account.
LexBlog IP
FEBRUARY 21, 2023
9,186,208 on surgical devices for a procedure called endometrial ablation were anticipated under the public use bar of pre-AIA 35 U.S.C. § Minerva did not disclose the devices under any confidentiality obligations, despite the commercial nature of the event. § 102(b).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trading Secrets
APRIL 18, 2023
Disclosure of Patentable Ideas To figure out if disclosing invention details to ChatGPT is a public disclosure under patent law, we need to see if it can be categorized as a description in a printed publication, public use, or public sale. enablement). enablement). Thankfully, the U.S.
LexBlog IP
APRIL 18, 2023
Disclosure of Patentable Ideas To figure out if disclosing invention details to ChatGPT is a public disclosure under patent law, we need to see if it can be categorized as a description in a printed publication, public use, or public sale. enablement). enablement). Thankfully, the U.S.
LexBlog IP
APRIL 18, 2023
Disclosure of Patentable Ideas To figure out if disclosing invention details to ChatGPT is a public disclosure under patent law, we need to see if it can be categorized as a description in a printed publication, public use, or public sale. enablement). enablement). Thankfully, the U.S.
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
As of March 23, 2020, Mylan’s NDA for Semglee™ was “deemed” to be a BLA, and Mylan has announced its submission of “all necessary documentation” to FDA for approval of Semglee™ as a biosimilar and interchangeable biosimilar product. Market uptake of biosimilars has generally trended upwards in 2020. Not yet launched. etanercept).
Expert insights. Personalized for you.
52 
Let's personalize your content